CZ280718B6 - Způsob přípravy 1beta-ethyl-1alfa-(hydroxymethyl) -1,2,3,4,6,7,12,12balfa-oktahydro-indolo /2,3-a/ chinolizinu a nových meziproduktů - Google Patents
Způsob přípravy 1beta-ethyl-1alfa-(hydroxymethyl) -1,2,3,4,6,7,12,12balfa-oktahydro-indolo /2,3-a/ chinolizinu a nových meziproduktů Download PDFInfo
- Publication number
- CZ280718B6 CZ280718B6 CS922047A CS204792A CZ280718B6 CZ 280718 B6 CZ280718 B6 CZ 280718B6 CS 922047 A CS922047 A CS 922047A CS 204792 A CS204792 A CS 204792A CZ 280718 B6 CZ280718 B6 CZ 280718B6
- Authority
- CZ
- Czechia
- Prior art keywords
- ethyl
- quinolizine
- indolo
- hydroxymethyl
- formula
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000000543 intermediate Substances 0.000 title abstract description 7
- 238000004519 manufacturing process Methods 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 35
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims abstract description 30
- 239000000203 mixture Substances 0.000 claims description 29
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 20
- 150000003839 salts Chemical class 0.000 claims description 20
- 239000002585 base Substances 0.000 claims description 16
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 11
- 229920002866 paraformaldehyde Polymers 0.000 claims description 11
- MTEOGEBTRZOKPM-UHFFFAOYSA-N 1-ethyl-2,3,4,6,7,12-hexahydroindolo[2,3-a]quinolizine Chemical compound N1C2=CC=CC=C2C2=C1C1=C(CC)CCCN1CC2 MTEOGEBTRZOKPM-UHFFFAOYSA-N 0.000 claims description 10
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 8
- 239000012458 free base Substances 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- BKRBRZLECKMEBD-UHFFFAOYSA-N (1-ethyl-3,4,6,7,12,12b-hexahydro-2h-indolo[2,3-a]quinolizin-1-yl)methanol Chemical compound C1=CC=C2C(CCN3CCCC(C43)(CO)CC)=C4NC2=C1 BKRBRZLECKMEBD-UHFFFAOYSA-N 0.000 claims description 5
- 239000012279 sodium borohydride Substances 0.000 claims description 5
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 5
- 239000000010 aprotic solvent Substances 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 4
- 238000009903 catalytic hydrogenation reaction Methods 0.000 claims description 4
- 239000003638 chemical reducing agent Substances 0.000 claims description 4
- 238000002955 isolation Methods 0.000 claims description 4
- 125000000539 amino acid group Chemical group 0.000 claims description 3
- 239000012429 reaction media Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 42
- 230000002093 peripheral effect Effects 0.000 abstract description 2
- 230000000304 vasodilatating effect Effects 0.000 abstract description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 60
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 41
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 31
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- 239000007858 starting material Substances 0.000 description 14
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 11
- 238000003776 cleavage reaction Methods 0.000 description 11
- 230000007017 scission Effects 0.000 description 11
- -1 β-ethyl Chemical class 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- YONLFQNRGZXBBF-ZIAGYGMSSA-N (2r,3r)-2,3-dibenzoyloxybutanedioic acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=CC=C1 YONLFQNRGZXBBF-ZIAGYGMSSA-N 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 229940095064 tartrate Drugs 0.000 description 9
- 239000013078 crystal Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- VUWFVAPKKYSYLJ-UHFFFAOYSA-N (1-ethyl-3,4,6,7-tetrahydro-2h-indolo[2,3-a]quinolizin-1-yl)methanol Chemical compound C1=CC=CC2=NC3=C4C(CC)(CO)CCCN4CCC3=C21 VUWFVAPKKYSYLJ-UHFFFAOYSA-N 0.000 description 2
- WCJSIHHWFYNIQC-UHFFFAOYSA-N 1,2,3,4,6,7-hexahydroindolo[2,3-a]quinolizine Chemical compound N1=C2C=CC=CC2=C2C1=C1CCCCN1CC2 WCJSIHHWFYNIQC-UHFFFAOYSA-N 0.000 description 2
- SNJHPBCJDWASBR-UHFFFAOYSA-O 1-ethyl-2,3,4,6,7,12-hexahydro-1h-indolo[2,3-a]quinolizin-5-ium Chemical compound N1C2=CC=CC=C2C(CC2)=C1C1=[N+]2CCCC1CC SNJHPBCJDWASBR-UHFFFAOYSA-O 0.000 description 2
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N 3-Methylbutan-2-one Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 description 2
- GDRVFDDBLLKWRI-UHFFFAOYSA-N 4H-quinolizine Chemical compound C1=CC=CN2CC=CC=C21 GDRVFDDBLLKWRI-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- FVLANYFSTPCTHK-UHFFFAOYSA-N 1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-1-ylmethanol Chemical compound C1=CC=C2C3CCN4CCCC(CO)C4C3NC2=C1 FVLANYFSTPCTHK-UHFFFAOYSA-N 0.000 description 1
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 1
- SNJHPBCJDWASBR-UHFFFAOYSA-N 1-ethyl-1,2,3,4,6,7-hexahydroindolo[2,3-a]quinolizine Chemical compound C1=CC=CC2=NC3=C4C(CC)CCCN4CCC3=C21 SNJHPBCJDWASBR-UHFFFAOYSA-N 0.000 description 1
- KJIDVKDDQARNFN-UHFFFAOYSA-N 1-ethyl-2,3,4,5,6,7-hexahydro-1h-indolo[2,3-a]quinolizin-5-ium;perchlorate Chemical compound [O-]Cl(=O)(=O)=O.N1C2=CC=CC=C2C(CC2)=C1C1=[N+]2CCCC1CC KJIDVKDDQARNFN-UHFFFAOYSA-N 0.000 description 1
- IVAZUYDBZBQJQZ-UHFFFAOYSA-N CCC(CCC1)C2=[N+]1CCC1=C2NC2=CC=CC=C12.[Cl-] Chemical compound CCC(CCC1)C2=[N+]1CCC1=C2NC2=CC=CC=C12.[Cl-] IVAZUYDBZBQJQZ-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 125000005042 acyloxymethyl group Chemical group 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960001270 d- tartaric acid Drugs 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- NTBIYBAYFBNTCD-UHFFFAOYSA-N dibenzoyl 2,3-dihydroxybutanedioate Chemical compound C=1C=CC=CC=1C(=O)OC(=O)C(O)C(O)C(=O)OC(=O)C1=CC=CC=C1 NTBIYBAYFBNTCD-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU906952A HU207070B (en) | 1990-10-31 | 1990-10-31 | Process for producing 1beta-ethyl-1alpha-hydroxymethyl-1,2,3,4,6,712,12balpha-octahydroindolo(2,3-a) quinolizine |
| PCT/HU1991/000046 WO1992007851A1 (en) | 1990-10-31 | 1991-10-30 | PROCESS FOR THE PREPARATION OF 1β-ETHYL-1α-(HYDROXYMETHYL)-1,2,3,4,6,7,12,12bα-OCTAHYDRO-INDOLO[2,3-a]QUINOLIZINE AND NOVEL INTERMEDIATES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS204792A3 CS204792A3 (en) | 1992-10-14 |
| CZ280718B6 true CZ280718B6 (cs) | 1996-04-17 |
Family
ID=10972062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS922047A CZ280718B6 (cs) | 1990-10-31 | 1992-06-30 | Způsob přípravy 1beta-ethyl-1alfa-(hydroxymethyl) -1,2,3,4,6,7,12,12balfa-oktahydro-indolo /2,3-a/ chinolizinu a nových meziproduktů |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5352790A (Direct) |
| EP (1) | EP0507914A1 (Direct) |
| JP (1) | JPH05503297A (Direct) |
| KR (1) | KR100211445B1 (Direct) |
| CN (1) | CN1040439C (Direct) |
| BG (1) | BG61894B2 (Direct) |
| CA (1) | CA2071878A1 (Direct) |
| CZ (1) | CZ280718B6 (Direct) |
| FI (1) | FI923042A7 (Direct) |
| GE (1) | GEP19981536B (Direct) |
| HU (1) | HU207070B (Direct) |
| LT (1) | LT3733B (Direct) |
| LV (1) | LV10272B (Direct) |
| NO (1) | NO300688B1 (Direct) |
| PL (1) | PL168526B1 (Direct) |
| RO (1) | RO109650B1 (Direct) |
| RU (1) | RU2056423C1 (Direct) |
| SK (1) | SK279484B6 (Direct) |
| TW (1) | TW223074B (Direct) |
| WO (1) | WO1992007851A1 (Direct) |
| ZA (1) | ZA918790B (Direct) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1064284T3 (da) * | 1998-03-17 | 2002-07-22 | Besins Int Lab | Hypnotiske beta-carbolinderivater, fremgangsmåde til fremstilling deraf og deres anvendelse som medicinske produkter |
| WO2010057055A2 (en) * | 2008-11-13 | 2010-05-20 | Halliburton Energy Services, Inc. | Downhole instrument calibration during formation survey |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU167366B (Direct) * | 1972-09-06 | 1975-09-27 | ||
| US4044012A (en) * | 1974-05-07 | 1977-08-23 | Richter Gedeon Vegyeszeti Gyar Rt. | Indolo-quinolizidine derivatives |
| HU170495B (Direct) * | 1974-05-07 | 1977-06-28 | ||
| GB1499546A (en) * | 1974-05-07 | 1978-02-01 | Richter Gedeon Vegyeszet | Indolo-quinolizidine derivatives and a process for the preparation thereof |
| HU194221B (en) * | 1985-04-19 | 1988-01-28 | Richter Gedeon Vegyeszet | Process for preparing novel octahydro-indolo/2,3-a/quinoline derivative and pharmaceutical comprising this compound |
-
1990
- 1990-10-31 HU HU906952A patent/HU207070B/hu not_active IP Right Cessation
-
1991
- 1991-10-30 PL PL91295417A patent/PL168526B1/pl unknown
- 1991-10-30 WO PCT/HU1991/000046 patent/WO1992007851A1/en not_active Ceased
- 1991-10-30 EP EP91918864A patent/EP0507914A1/en not_active Ceased
- 1991-10-30 RU SU915052287A patent/RU2056423C1/ru active
- 1991-10-30 CA CA002071878A patent/CA2071878A1/en not_active Abandoned
- 1991-10-30 US US07/877,172 patent/US5352790A/en not_active Expired - Fee Related
- 1991-10-30 FI FI923042A patent/FI923042A7/fi not_active Application Discontinuation
- 1991-10-30 JP JP3517150A patent/JPH05503297A/ja active Pending
- 1991-10-30 KR KR1019920701563A patent/KR100211445B1/ko not_active Expired - Fee Related
- 1991-10-30 RO RO92-0866A patent/RO109650B1/ro unknown
- 1991-10-30 SK SK2047-92A patent/SK279484B6/sk unknown
- 1991-11-05 ZA ZA918790A patent/ZA918790B/xx unknown
- 1991-11-16 CN CN91110744A patent/CN1040439C/zh not_active Expired - Fee Related
- 1991-12-06 TW TW080109625A patent/TW223074B/zh active
-
1992
- 1992-06-26 NO NO922545A patent/NO300688B1/no unknown
- 1992-06-30 CZ CS922047A patent/CZ280718B6/cs not_active IP Right Cessation
- 1992-12-30 LV LVP-92-688A patent/LV10272B/lv unknown
-
1993
- 1993-06-17 GE GEAP1993897A patent/GEP19981536B/en unknown
- 1993-11-25 LT LTIP1487A patent/LT3733B/lt unknown
- 1993-12-10 BG BG098289A patent/BG61894B2/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1072412A (zh) | 1993-05-26 |
| CS204792A3 (en) | 1992-10-14 |
| GEP19981536B (en) | 1998-11-13 |
| FI923042A0 (fi) | 1992-06-30 |
| NO922545L (no) | 1992-06-26 |
| FI923042L (fi) | 1992-06-30 |
| LTIP1487A (en) | 1995-06-26 |
| RU2056423C1 (ru) | 1996-03-20 |
| LV10272B (en) | 1995-10-20 |
| EP0507914A1 (en) | 1992-10-14 |
| PL168526B1 (en) | 1996-02-29 |
| SK279484B6 (sk) | 1998-12-02 |
| LV10272A (lv) | 1994-10-20 |
| WO1992007851A1 (en) | 1992-05-14 |
| HU906952D0 (en) | 1991-05-28 |
| FI923042A7 (fi) | 1992-06-30 |
| TW223074B (Direct) | 1994-05-01 |
| NO922545D0 (no) | 1992-06-26 |
| NO300688B1 (no) | 1997-07-07 |
| LT3733B (en) | 1996-02-26 |
| KR920703588A (ko) | 1992-12-18 |
| HU207070B (en) | 1993-03-01 |
| JPH05503297A (ja) | 1993-06-03 |
| CN1040439C (zh) | 1998-10-28 |
| BG61894B2 (bg) | 1998-08-31 |
| ZA918790B (en) | 1992-08-26 |
| KR100211445B1 (ko) | 1999-08-02 |
| US5352790A (en) | 1994-10-04 |
| CA2071878A1 (en) | 1992-05-01 |
| RO109650B1 (ro) | 1995-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5344926A (en) | Process for producing staurosporine derivatives | |
| WO1997003987A1 (fr) | Nouveaux derives de la galanthamine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant | |
| CZ280718B6 (cs) | Způsob přípravy 1beta-ethyl-1alfa-(hydroxymethyl) -1,2,3,4,6,7,12,12balfa-oktahydro-indolo /2,3-a/ chinolizinu a nových meziproduktů | |
| US3887606A (en) | Process for the preparation of DL-phenylglycine esters | |
| FR2510575A1 (fr) | Nouveaux composes bicycliques, leur procede de preparation et composition pharmaceutique les renfermant | |
| SU558644A3 (ru) | Способ получени имидазолов или их солей | |
| US4456611A (en) | Derivatives of 2-[3-(3-indoly)2-amino propionyloxy] acetic acid, and seritoning increasing use thereof | |
| US3086972A (en) | Aza-thiaxanthene derivatives | |
| US6127362A (en) | 9,10-diazatricyclo[4,4,1,12,5 ] decane and 2,7-diazatricyclo [4,4,0,03,8 ] decane derivatives having analgesic activity | |
| FR2625201A1 (fr) | Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant | |
| US4044012A (en) | Indolo-quinolizidine derivatives | |
| US6066647A (en) | Zwitterionic forms of trovafloxacin | |
| US2944064A (en) | Process for preparing 5-hydroxy-tryptamine through new intermediates | |
| FR2765580A1 (fr) | Derives de (1h-imidazol-4-yl)piperidine, leur preparation et leur application en therapeutique | |
| FR2607134A1 (fr) | Nouveaux derives de l'octahydrobenzo(g)quinoleine, leur preparation et leur utilisation comme medicaments | |
| IE913849A1 (en) | PROCESS FOR THE PREPARATION OF¹1ß-ETHYL-1Ó-(HYDROXYMETHYL)-1,2,3,4,6,7,12,12bÓ-OCTAHYDRO-¹INDOLO[2,3-a]QUINOLIZINE AND NOVEL INTERMEDIATES | |
| KR0184340B1 (ko) | N-치환 헤테로 고리 화합물 및 이의 제조방법 | |
| US4314063A (en) | 1-Ethyl-1,4,5,6-tetrahydro-6-(2-naphthyl)-4-oxo-nicotinic acid and lower alkyl esters thereof | |
| JP4866905B2 (ja) | イミダゾール−アミノ酸誘導体及び関連化合物の合成方法 | |
| EP0120832A1 (fr) | Alkyl-4-indolonaphtyridines et compositions pharmaceutiques les contenant | |
| JPS6037117B2 (ja) | ６−アミノペニシラン酸誘導体の製法 | |
| HRP920776A2 (en) | PROCESS FOR OBTAINING 1 BETA-ETHYL-1 ALPHA(HYDROXYMETHYL)-1,2,3,4,6,7,12,12b ALPHA-OCTAHYDRO-INDOLO (2,3-a) QUINOLIZINE AND NEW INTERMEDIATES | |
| GB2065113A (en) | Ergoline derivatives, their production and pharmaceutical compositions containing them | |
| IL32383A (en) | Process for preparing acylated derivatives of ypsilon-lactams of cephalosporin and compounds of this type | |
| HU185262B (en) | Process for producing new optically active hexahydro-indolo-bracket-2,3-a-bracket closed-quinolyzinium derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of fee |
Effective date: 19991030 |